More Substance Use News and Updates

Adial Pharmaceuticals announced that in its ONWARD Phase 3 clinical study, its AD04 medication achieved a statistically significant mean reduction in heavy drinking days among a prespecified group of “heavy drinkers” compared to a placebo.

Individuals under the age of 40—particularly males—face higher risks from alcohol consumption than older adults and receive no health benefits from consuming alcohol, according to new research published this month in The Lancet.

An increased risk of personal histories of trauma combined with a greater vulnerability to alcohol-related deficits in the brain appear to work together to lead to more severe alcohol use disorders in women compared with men.

The findings indicate underprescribing of such medications, despite their demonstrated effectiveness in reducing heavy drinking and/or relapse.

In people with alcohol use disorder, medical addiction pharmacotherapy is linked with reduced incidence and progression of alcohol-associated liver disease, according to study findings published online in JAMA Network Open.

Numerous chances for care providers to identify alcohol misuse going unnoticed, researchers say.

Better sleep habits indirectly reduced hazardous drinking among adults between the ages of 21 and 29, and reduced drinking was linked with improved sleep, according to a Penn State University study.

Moderate average drinkers with a pattern of engaging in binge drinking were found to be almost 5 times more likely to experience multiple alcohol-related problems, compared with individuals who drink the same amount overall but don’t binge.

COVID-19-related changes to buprenorphine prescribing guidelines improved opioid use disorder patient outcomes, according to Drexel University researchers.

While a majority of Americans said their mood overall has stabilized since January, nearly 1 in 5 said they have increased their alcohol consumption or smoking, according to recent study data.